New YorkRelates to the labeling of mifepristone, misoprostol, and their generic alternatives
What it does
Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Jan 22SUBSTITUTED BY S36ALatest
- Jan 22ORDERED TO THIRD READING RULES CAL.61
- Jan 22RULES REPORT CAL.61
- Jan 22REPORTED
- Jan 22REPORTED REFERRED TO RULESMinor
- Jan 16PRINT NUMBER 2145AMajor
- Jan 16AMEND (T) AND RECOMMIT TO HIGHER EDUCATIONMajor
- Jan 15REFERRED TO HIGHER EDUCATIONIntroduced